| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19832f7a81121085475b833c44c73b24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71321ff1a1eeda093fcc3972306efe21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab8d9edec80ff94cb1efb0733c4c2e35 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N2-00 |
| filingDate |
2010-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69b0426a20fab968b381b65feb26ee0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff07bd3bc43fafb96496adcba3a6b8e6 |
| publicationDate |
2012-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012021010-A1 |
| titleOfInvention |
Antiplatelet agent and methods of using the same |
| abstract |
Disclosed herein are compositions and methods for inhibiting platelet aggregation in a patient in need thereof. The compositions and methods use superparamagnetic iron oxide nanoparticles (SPIONs), which are shown to inhibit aggregation of platelets. Such methods are useful in preventing blood clotting in diseases such as acute coronary syndrome. Also disclosed are in vitro methods of sensing platelet function using SPIONs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10159734-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10813997-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10646241-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021382036-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612655-B2 |
| priorityDate |
2010-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |